A $7.1 Billion Signal That Domestic Manufacturing Is Back

Virginia just signed four new laws creating grant programs to support manufacturing facilities valued at approximately $7.1 billion. The beneficiaries — Avio USA, Hitachi Energy, Eli Lilly, and AstraZeneca — represent pharma, energy, and aerospace. But the ripple effects extend far beyond those sectors.

When state governments start writing legislation specifically designed to attract manufacturing investment, it tells us something important: the U.S. is serious about reshoring production, and the economics of where and how goods are made are shifting fast.

For beauty and personal care brands, this moment deserves close attention.

Key Takeaway #1: Incentives Signal Rising Domestic Manufacturing Costs

Virginia needed to create grant programs to make these mega-projects viable. That's because building and operating manufacturing facilities in the U.S. remains expensive — labor costs, permitting timelines, and infrastructure demands haven't gone away. For CPG brands without the leverage of an Eli Lilly or AstraZeneca, competing for U.S. manufacturing capacity is only going to get harder and more costly.

This is exactly why nearshore manufacturing in Latin America has gained traction. You get geographic proximity and tariff advantages without the overhead that requires state-level subsidies to pencil out.

Key Takeaway #2: Supply Chain Resilience Is Now a Legislative Priority

These laws aren't just about jobs — they're about supply chain security. Legislators are betting that having critical manufacturing closer to end markets reduces risk. The same logic applies to beauty and personal care. Brands that rely on contract manufacturers in Asia face 30-to-90-day ocean freight timelines, tariff exposure, and geopolitical uncertainty. Nearshore partners in Latin America cut lead times to days, not months, while keeping brands within favorable trade frameworks like USMCA.

Key Takeaway #3: The Window to Act Is Now

As more capital flows into U.S.-based manufacturing for pharma, energy, and defense, the competition for skilled labor, raw materials, and logistics infrastructure will intensify. Smaller CPG brands that wait to diversify their manufacturing footprint may find themselves squeezed out or paying premium prices.

At CosmeticMFG, we help beauty and personal care brands build resilient, cost-efficient supply chains through nearshore manufacturing in Latin America — so they can move fast without the overhead of a $7 billion state incentive package.

Don't Wait for the Squeeze

The manufacturing landscape is evolving rapidly. Whether it's tariff reform, reshoring incentives, or shifting logistics costs, brands that plan proactively will win. Visit cosmeticmfg.com to learn how nearshore manufacturing can future-proof your supply chain.